Recital 21, Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refu…

In forcesince 29 Oct 2009

Following an application from the Institute of Biotechnology, Sera and Vaccines Biomed SA, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Lactoral on the living probiotic bacteria (Question No EFSA-Q-2008-480) [The EFSA Journal (2008) 862, pp. 1-2.]. The claim proposed by the applicant was worded as follows: ‘Lactoral contains living probiotic bacteria with strong ability to intestinal tract colonisation, isolated from healthy, naturally fed infants’.